KRAS and cancer: Table 3 shows crude and adjusted odds ratios and 95% confidence intervals for TP53, KRAS, and KRAS G12C/V mutation status for every IQR (3.3 μg/m3) increase in PM2.5 exposure five or ten years prior to cancer diagnosis.